FDA Approved: LEVETIRACETAM — Original Application (Eugia US LLC)

View source ↗

Summary

The FDA approved an Abbreviated New Drug Application (ANDA) for levetiracetam from Eugia US LLC, authorizing the marketing of a generic version.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Generalized Tonic-clonic Epilepsy
• Juvenile Myoclonic Epilepsy
• Partial-onset Seizures

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

ORIG AP for LEVETIRACETAM (LEVETIRACETAM)